Mike Hoff

Hank McMonigle And Dana Hall Join LDR Interactive’s TopicPulse Management Team

LDR INTERACTIVE has hired two new executives to its TOPICPULSE leadership team. HANK MCMONIGLE joins as VP/Sales and DANA HALL joins as Support and Client Services Manager. Read more: http://www.allaccess.com/net-news/archive/story/128411/hank-mcmonigle-and-dana-hall-join-ldr-interactive-#ixzz2xx8Ay51T

GenomOncology is searching for a method that sticks

A cancer patient’s genome is like a haystack. The gene that caused the cancer is the needle. And Manuel Glynias is selling a huge horseshoe magnet. http://www.crainscleveland.com/article/20140309/SUB1/303099983

Agreement sets stage for enhanced My Cancer Genome

Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. http://news.vanderbilt.edu/2014/02/agreement-sets-stage-for-enhanced-my-cancer-genome/

GenomOncology receives investment from TriStar Technology Ventures

http://bit.ly/LFiN08 GenomOncology, a Westlake company that has developed software platforms to automate the analysis of sequenced genetic information, said it has received an investment from TriStar Technology Ventures, a health care innovation venture firm based in Nashville, Tenn.

LDR Interactive Becomes Futuri Media

LDR INTERACTIVE has become FUTURI MEDIA, bolstering its management team with two key appointments. Media and technology industry veteran BRIAN PARSONS has joined FUTURI MEDIA as Chief Information Officer, having served as an EVP for iHEARTMEDIA and TRITON DIGITAL MEDIA. PARSONS and Chief Technology Officer BRIAN SEEDERS, a founding team member, will lead product innovation …

LDR Interactive Becomes Futuri Media Read More »

Cleveland Clinic doctor is taking fight vs. disease to heart

http://www.crainscleveland.com/article/20140126/SUB1/301269990 “Some of Dr. Hazen’s findings have contributed to the growth of Cleveland HeartLab. It’s a successful Clinic spinoff that now employs 120 people and tests blood samples and other specimens to help doctors determine whether patients are at risk of a heart attack or other medical problems.”